skin cancer Archive — Page 2 of 6

VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
March 25, 2021

Forty-three percent of melanoma patients have chronic complications from immunotherapies

Chronic side effects among melanoma survivors after treatment with anti-PD-1 immunotherapies are more common than previously recognized, according to a study published March 25 in JAMA Oncology.

By Tom Wilemon
Ann Richmond, MD, Chi Yan, PhD, Jinming Yang, PhD, and colleagues are studying ways to boost antitumor immunity and reduce tumor growth in breast cancer and melanoma.
December 17, 2020

Study reveals new strategy for reducing tumor growth, metastasis

A team of Vanderbilt investigators has discovered that blocking a certain signaling pathway boosts antitumor immunity and reduces tumor growth and metastasis in models of breast cancer and melanoma.

By Leigh MacMillan
April 23, 2020

Study explores melanoma drug’s effectiveness

A study by Vanderbilt research-ers supports the clinical development of a new second-line treatment for metastatic melanoma.

By Tom Wilemon
Two researchers pose in a laboratory, with one standing beside another seated at a workstation wearing pink gloves; lab equipment and supplies fill the background.
August 15, 2019

Potential second-line melanoma treatment identified

A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients.

By Tom Wilemon
Portrait of Tom Deweese wearing glasses and a light blue checkered shirt indoors.
March 28, 2019

Hot chemotherapy surgery helps save patient’s leg

Tom Deweese can keep up with his grandchildren because of a highly specialized surgery using hot chemotherapy that saved his leg.

By Tom Wilemon
Smiling gray-haired man in a plaid shirt sits beside a stone fireplace, holding a black-and-brown dog.
May 22, 2018

A Second Chance

By Tom Wilemon